Somerset Indus At A Glance

Year
Founded
0
Total Funds
Raised
$0MN
Companies
Funded
0
Companies
Fully Exited
0
Partners' Cumulative
Experience
0+ Years
Sustainable Development
Goals Served
0

About Somerset Indus

Somerset Indus is a healthcare focused private equity firm making private equity and equity-related investments primarily in growth-oriented healthcare companies in India.

Somerset Indus Healthcare Fund was founded in 2011 by Avinash Kenkare, a private equity professional with 20+ years of successful investing experience in healthcare; and Somerset Indus Healthcare India Fund by Mayur Sirdesai, a healthcare/ pharma professional with over 20+ years of experience in the Indian Pharma/ Healthcare Industry across private equity, operational and consulting services.

In 2018, Somerset Indus setup its second Fund. The team was strengthened by bringing on board two new partners. Kannan Ramesh with 25 years’ experience in healthcare delivery and fundraising and Sharad Ladha with 20 years’ experience in private equity, consulting and insurance related experience.

Somerset Indus aims to invest in healthcare delivery product and service platforms run by experienced healthcare entrepreneurs which are focused on providing quality and affordable healthcare across India, especially in the lower tier markets. Somerset Indus through its investment thesis of profitable and sustainable impact based investing has been supporting capacity build up and aims to deliver accessibility and affordability to healthcare in India with a key focus on creating a positive impact on the environment, society, and governance.

The team uses its successful private equity investment experience, healthcare systems knowledge, in depth India specific healthcare experience and knowledge base to make investments in Indian healthcare companies and deploys the capital successfully to grow businesses and increase profitability. The firm believes in following a disciplined approach towards investing and makes all efforts to support the portfolio companies as well as potential investee companies in terms of operational support, accesses to our healthcare networks, talent acquisition and support on strategic and execution related matters of the companies.

Mission

“To partner with healthcare entrepreneurs and help in providing the right impetus operationally and financially, to increase availability, accessibility, affordability and provide quality healthcare to the underserved and privileged India also using technology as an enabler”

Vision

“To become the preferred strategic, operational and financial partner of choice in the healthcare sector in India and to grow to size and scale in pre dominantly tier II, tier III markets”

Key Differentiators

  • A team of investment professionals having extensive knowledge, relationships with domestic players, access to and experience dealing with global participants that can bring new technologies and provide access to new markets
  • Active handholding as first institutional investors
  • Extensive fund engagement with portfolio companies in areas of portfolio expansion, talent acquisition and strategy and operational aspects
  • Active involvement of external networks to add value to portfolio companies
  • Strong focus on ESG and sustainable impact investing across the investment cycle
  • Capturing the strong deal flow opportunities of the SME space especially in the recession resistant healthcare sector in India

Our Story Timeline

Cool Timeline

January 2011

2011

Fund Formed by Avinash Kenkare and Mayur Sirdesai

May 2011

May-11

Sandor Medicaids Investment

July 2012

Jul-12

Express Clinics Investment

March 2013

Mar-13

Cygnus Medicare Investment

February 2014

Feb-14

Prognosys Medical Systems Investment

October 2014

Oct-14

Express Clinics Exit

July 2015

Jul-15

Krsnaa Diagnostics Investment

November 2015

Nov-15

Browndove Healthcare Investment

January 2016

Jan-16

Sandor Medicaids Exit

November 2016

Nov-16

Hexagon Nutrition Investment

February 2017

Feb-17

ESG theme incorporated

January 2018

Jan-18

Fund II Fundraising Starts

May 2019

May-19

Apex Hospitals Investment

May 2019

May-19

Genworks Health Investment

November 2019

November 2019

Cygnus Hospitals Partial Exit

August 2021

August 2021

Krsnaa Diagnostics Partial Exit

September 2021

September 2021

Globela Pharma Investment

June 2022

June 2022

Sterling Hospitals Investment

April 2023

April 2023

EMIL Invetsment

May 2023

May 23

Krsnaa Diagnostics Full Exit

June 2023

Jun 2023

Chayagraphics Full Exit

June 2023

Jun 2023

Natural Biogenex

February 2024

February 2024

Printmann Offset Investment

March 2024

March 2024

Ujala Cygnus Full Exit

June 2024

June 2024

Fund III Launched

INVESTMENT PHILOSOPHY

The Fund makes controlling or influential minority investments in small and mid-sized Indian companies in the healthcare services and products sector.